{"protocolSection":{"identificationModule":{"nctId":"NCT01901874","orgStudyIdInfo":{"id":"GCS 10-08"},"organization":{"fullName":"W.L.Gore & Associates","class":"INDUSTRY"},"briefTitle":"The Gore SCAFFOLD Clinical Study","officialTitle":"GORE® Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis in Patients at Increased Risk for Adverse Events From Carotid Endarterectomy"},"statusModule":{"statusVerifiedDate":"2020-10","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2013-07","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2017-12","type":"ACTUAL"},"completionDateStruct":{"date":"2020-09","type":"ACTUAL"},"studyFirstSubmitDate":"2013-07-12","studyFirstSubmitQcDate":"2013-07-12","studyFirstPostDateStruct":{"date":"2013-07-17","type":"ESTIMATED"},"resultsFirstSubmitDate":"2019-04-09","resultsFirstSubmitQcDate":"2019-04-09","resultsFirstPostDateStruct":{"date":"2019-05-03","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-10-05","lastUpdatePostDateStruct":{"date":"2020-10-29","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"W.L.Gore & Associates","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"Evaluate the safety and efficacy of the GORE® Carotid Stent for the treatment of carotid artery stenosis in patients at increased risk for adverse events from carotid endarterectomy","detailedDescription":"This is a prospective, multicenter, single-arm clinical study comparing outcomes with the GORE® Carotid Stent to a performance goal derived from carotid endarterectomy outcomes in high-surgical-risk patients."},"conditionsModule":{"conditions":["Carotid Artery Disease","Carotid Artery Stenosis"],"keywords":["Stroke","Carotid Artery Stenting (CAS)","Embolic Protection Device (EPD)","Stent","Carotid Stenosis","Constriction, Pathologic","Carotid Artery Diseases","Cerebrovascular Disorders","Brain Diseases","Central Nervous System Diseases","Nervous System Diseases","Arterial Occlusive Diseases","Vascular Diseases","Cardiovascular Diseases","Pathological Conditions, Anatomical","Angioplasty"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":312,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Carotid Artery Stenting","type":"EXPERIMENTAL","description":"Carotid Artery Stenting with the GORE® Carotid Stent","interventionNames":["Device: Carotid Artery Stenting"]}],"interventions":[{"type":"DEVICE","name":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent","armGroupLabels":["Carotid Artery Stenting"],"otherNames":["GORE® Carotid Stent"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants Who Experienced Major Adverse Events (MAE) at One Year","description":"MAE defined as any death, stroke, or myocardial infarction through 30 days post-index procedure, or ipsilateral stroke between 31 days and 1 year (365 days).","timeFrame":"365 days"}],"secondaryOutcomes":[{"measure":"Number of Participants Who Achieved Stent Technical Success","description":"Stent Technical Success defined as successful implantation of a GORE® Carotid Stent","timeFrame":"Procedural"},{"measure":"Number of Participants Who Achieved Embolic Protection Device (EPD) Technical Success","description":"EPD Technical Success defined as GORE® Embolic Filter delivered, placed, and retrieved without requiring assisting interventional methods.","timeFrame":"Procedural"},{"measure":"Number of Participants Who Achieved Procedure Success","description":"Procedure Success defined as Stent Technical Success with \\< 30% residual stenosis and no in-hospital MAE.","timeFrame":"Procedural"},{"measure":"Number of Participants Who Experienced MAE at 30 Days","description":"Defined as any death, stroke, or myocardial infarction through 30 days post-index procedure.","timeFrame":"30 days"},{"measure":"30-Day MAE - Death","description":"Any cause death through 30 days post-index procedure","timeFrame":"30 days"},{"measure":"30-Day MAE - Myocardial Infarction","description":"Any myocardial infarction through 30 days post-index procedure","timeFrame":"30 days"},{"measure":"30-Day MAE - Stroke","description":"Any stroke through 30 days post-index procedure","timeFrame":"30 days"},{"measure":"In-Stent Restenosis","description":"≥80% diameter stenosis within the stented lesion or within 5 mm proximal or distal to the stent at follow-up evaluation by core lab angiographic analysis","timeFrame":"365 days"},{"measure":"Target Lesion Revascularization","description":"Any clinically driven revascularization procedure that is performed to increase the luminal diameter inside or within 5 mm of the previously treated lesion","timeFrame":"365 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient is at least 18 years old at informed consent\n* Patient is willing and capable of complying with all study protocol requirements, including specified follow-up period and can be contacted by telephone.\n* Patient is willing to provide written informed consent prior to enrollment in study.\n* Patient is either:\n\n  * Symptomatic with carotid stenosis ≥50% as determined by angiography using NASCET methodology. Symptomatic is defined as amaurosis fugax ipsilateral to the carotid lesion; Transient Ischemic Attack (TIA) or non-disabling stroke within 180 days of the procedure within the hemisphere supplied by the target vessel; OR\n  * Asymptomatic with carotid stenosis ≥80% as determined by angiography using NASCET methodology\n* Patient must be considered high risk for adverse events during carotid endarterectomy\n\nNote: Additional inclusion criteria may apply\n\nExclusion Criteria:\n\n* Patient has life expectancy of less than one year.\n* Patient is experiencing (or has experienced) an evolving, acute, or recent disabling stroke.\n* Patient has anticipated or potential sources of emboli (e.g. atrial fibrillation, known previously symptomatic patent foramen ovale (PFO), mechanical heart valve, or Deep Vein Thrombosis (DVT) treated within 6 months).\n* Patient has had an acute myocardial infarction within 72 hours prior to the index procedure.\n* Patient has a history of major, disabling ipsilateral stroke with residual deficit that may confound the neurological subject assessments.\n* Patient has known severe carotid stenosis contralateral to the target lesion requiring treatment within 30 days following the index procedure.\n\nNote: Additional exclusion criteria may apply","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"William Gray, MD","affiliation":"Lankenau Heart Institute","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Peter Schneider, MD","affiliation":"Kaiser Health System, Honolulu","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Kaiser Permanente Hawaii","city":"Honolulu","state":"Hawaii","zip":"96819","country":"United States","geoPoint":{"lat":21.30694,"lon":-157.85833}},{"facility":"Lankenau Heart Institute","city":"Wynnewood","state":"Pennsylvania","zip":"19096","country":"United States","geoPoint":{"lat":40.00289,"lon":-75.27074}}]},"referencesModule":{"references":[{"pmid":"31713310","type":"DERIVED","citation":"Gray WA, Levy E, Bacharach JM, Metzger DC, Randall B, Siddiqui A, Schonholz C, Alani F, Schneider PA. Evaluation of a novel mesh-covered stent for treatment of carotid stenosis in patients at high risk for endarterectomy: 1-year results of the SCAFFOLD trial. Catheter Cardiovasc Interv. 2020 Jul;96(1):121-127. doi: 10.1002/ccd.28586. Epub 2019 Nov 11."}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"periods":[{"title":"Procedure","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"312"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"312"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"}]}]},{"title":"Screening Committee Retrospective Review","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"312"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"265"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"47"}]}],"dropWithdraws":[{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"47"}]}]},{"title":"30-Day MAE Evaluation","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"265"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"264"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1"}]}],"dropWithdraws":[{"type":"Insufficient Follow-up","reasons":[{"groupId":"FG000","numSubjects":"1"}]}]},{"title":"1-Year (365-Day) MAE Evaluation","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"264"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"244"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"20"}]}],"dropWithdraws":[{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"7"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"5"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"2"}]},{"type":"Insufficient Follow-up","reasons":[{"groupId":"FG000","numSubjects":"6"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"Per protocol subjects","groups":[{"id":"BG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"265"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"73.1","spread":"8.8"}]}]}]},{"title":"Age, Continuous","paramType":"MEDIAN","dispersionType":"FULL_RANGE","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"74.4","lowerLimit":"45.8","upperLimit":"92.8"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"89"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"176"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"5"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"258"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"2"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"1"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"2"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"7"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"252"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"3"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"}]}]}]},{"title":"Diabetes Mellitus","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"107"}]}]}]},{"title":"Hypertension","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"249"}]}]}]},{"title":"Cigarette Smoking","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Current or stopped <12 months ago","measurements":[{"groupId":"BG000","value":"67"}]},{"title":"Previous (stopped >12 months ago)","measurements":[{"groupId":"BG000","value":"139"}]},{"title":"Never","measurements":[{"groupId":"BG000","value":"59"}]}]}]},{"title":"Previous Carotid Disease","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"125"}]}]}]},{"title":"Symptomatic","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"33"}]}]}]},{"title":"History of Ischemic Stroke","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"48"}]}]}]},{"title":"History of Transient Ischemic Attack (TIA)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"40"}]}]}]},{"title":"Ipsilateral Amaurosis Fugax or Transient Monocular Blindness (TMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}]}]},{"title":"Endarterectomy","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"79"}]}]}]},{"title":"Target Lesion Location","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"ICA","measurements":[{"groupId":"BG000","value":"235"}]},{"title":"Bifurcation","measurements":[{"groupId":"BG000","value":"30"}]}]}]},{"title":"Target Vessel Reference Diameter (mm)","paramType":"MEDIAN","dispersionType":"FULL_RANGE","unitOfMeasure":"millimeters","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5.5","lowerLimit":"3.7","upperLimit":"9.0"}]}]}]},{"title":"Target Lesion Length (mm)","paramType":"MEDIAN","dispersionType":"FULL_RANGE","unitOfMeasure":"millimeters","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"20","lowerLimit":"1","upperLimit":"40"}]}]}]},{"title":"Target Lesion % Diameter Stenosis","description":"= (RVD - MLD) / RVD x 100, where RVD = Reference Vessel Diameter (mm) and MLD = Minimum Lumen Diameter (mm)","paramType":"MEDIAN","dispersionType":"FULL_RANGE","unitOfMeasure":"percentage of vessel diameter","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"85","lowerLimit":"50","upperLimit":"99"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants Who Experienced Major Adverse Events (MAE) at One Year","description":"MAE defined as any death, stroke, or myocardial infarction through 30 days post-index procedure, or ipsilateral stroke between 31 days and 1 year (365 days).","populationDescription":"Per protocol subjects with 1-year MAE evaluation","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"365 days","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"244"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}]}],"analyses":[{"groupIds":["OG000"],"groupDescription":"Test null hypothesis of equal or greater proportion with 1-year MAE compared to a performance goal (PG).\n\nH0: P ≥ 16.9% vs H1: P \\< 16.9%, where P is the true proportion of CAS subjects with 1-year MAE and 16.9% is the PG based on outcomes reported for patients treated with carotid endarterectomy (CEA).\n\nN=280 subjects provide ≥90% power to exclude PG with 95.1% confidence if P=10.2% under H1.","nonInferiorityType":"OTHER","nonInferiorityComment":"Acceptable performance: favorably exclude PG=16.9% with 95.1% confidence.\n\nWa = expected weight (proportion) anatomic = 35% Pa = CEA expected anatomic MAE = 11% Wc = expected weight (proportion) comorbid = 65% Pc = CEA expected comorbid MAE = 14% D = noninferiority delta = 4%\n\nPG = 0.35 x 11% + 0.65 x 14% + 4% = 16.9%","pValue":"<0.00001","pValueComment":"A priori 1-sided alpha = 0.049 (from simulation) to ensure overall type-1 error rate ≤ 0.05.","statisticalMethod":"Binomial test (normal approximation)","paramType":"Weighted binomial proportion","paramValue":"0.0448","ciPctValue":"95.1","ciNumSides":"ONE_SIDED","ciUpperLimit":"0.0846","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.0241","estimateComment":"Weighted by expected fractions of anatomic and comorbid high risk subjects (35% and 65%, respectively). Standard error based on H0."}]},{"type":"SECONDARY","title":"Number of Participants Who Achieved Stent Technical Success","description":"Stent Technical Success defined as successful implantation of a GORE® Carotid Stent","populationDescription":"Per protocol subjects","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Procedural","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"265"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"265"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Achieved Embolic Protection Device (EPD) Technical Success","description":"EPD Technical Success defined as GORE® Embolic Filter delivered, placed, and retrieved without requiring assisting interventional methods.","populationDescription":"Per protocol subjects","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Procedural","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"265"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"251"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Achieved Procedure Success","description":"Procedure Success defined as Stent Technical Success with \\< 30% residual stenosis and no in-hospital MAE.","populationDescription":"Per protocol subjects","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Procedural","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"265"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"250"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Experienced MAE at 30 Days","description":"Defined as any death, stroke, or myocardial infarction through 30 days post-index procedure.","populationDescription":"Per protocol subjects with 30-day MAE evaluation","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"30 days","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"264"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8"}]}]}]},{"type":"SECONDARY","title":"30-Day MAE - Death","description":"Any cause death through 30 days post-index procedure","populationDescription":"Per protocol subjects with 30-day MAE evaluation","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"30 days","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"264"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}]},{"type":"SECONDARY","title":"30-Day MAE - Myocardial Infarction","description":"Any myocardial infarction through 30 days post-index procedure","populationDescription":"Per protocol subjects with 30-day MAE evaluation","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"30 days","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"264"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}]},{"type":"SECONDARY","title":"30-Day MAE - Stroke","description":"Any stroke through 30 days post-index procedure","populationDescription":"Per protocol subjects with 30-day MAE evaluation","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"30 days","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"264"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}]}]},{"type":"SECONDARY","title":"In-Stent Restenosis","description":"≥80% diameter stenosis within the stented lesion or within 5 mm proximal or distal to the stent at follow-up evaluation by core lab angiographic analysis","populationDescription":"Per protocol subjects","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"365 days","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"265"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}],"analyses":[{"groupIds":["OG000"],"nonInferiorityType":"OTHER","paramType":"Cumulative probability","paramValue":"0.018","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.007","ciUpperLimit":"0.047","estimateComment":"Kaplan-Meier product-limit method (Greenwood's formula for standard error)"}]},{"type":"SECONDARY","title":"Target Lesion Revascularization","description":"Any clinically driven revascularization procedure that is performed to increase the luminal diameter inside or within 5 mm of the previously treated lesion","populationDescription":"Per protocol subjects","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"365 days","groups":[{"id":"OG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"265"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}]}],"analyses":[{"groupIds":["OG000"],"nonInferiorityType":"OTHER","paramType":"Cumulative probability","paramValue":"0.022","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.009","ciUpperLimit":"0.052","estimateComment":"Kaplan-Meier product-limit method (Greenwood's formula for standard error)"}]}]},"adverseEventsModule":{"frequencyThreshold":"1","timeFrame":"395 days (end of 1-year follow-up window)","eventGroups":[{"id":"EG000","title":"Carotid Artery Stenting","description":"Carotid Artery Stenting with the GORE® Carotid Stent\n\nCarotid Artery Stenting: Carotid Artery Stenting with the GORE® Carotid Stent","deathsNumAffected":11,"deathsNumAtRisk":265,"seriousNumAffected":104,"seriousNumAtRisk":265,"otherNumAffected":110,"otherNumAtRisk":265}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":265}]},{"term":"Disseminated intravascular coagulation","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Atrial tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Left ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Pulseless electrical activity","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Sinus tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Diplopia","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Haematemesis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Large intestine polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Oesophageal varices haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Retroperitoneal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Adverse drug reaction","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Gait disturbance","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Non-cardiac chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Vascular stent restenosis","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":10,"numAtRisk":265}]},{"term":"Vascular stent thrombosis","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Hepatic cirrhosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Osteomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":265}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Anaemia postoperative","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Autonomic dysreflexia","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Carotid artery restenosis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Comminuted fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Extradural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":265}]},{"term":"Procedural hypotension","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Vascular pseudoaneurysm","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Blood creatinine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Metabolic acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Chondrocalcinosis pyrophosphate","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Osteonecrosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Spinal osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Synovial cyst","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Adenosquamous cell lung cancer stage III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Lung neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Pancreatic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Squamous cell carcinoma of lung","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Ataxia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Carotid artery dissection","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Carotid artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":265}]},{"term":"Carpal tunnel syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":265}]},{"term":"Dementia Alzheimer's type","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Generalised tonic-clonic seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":265}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":265}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Parkinson's disease","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Device breakage","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Device malfunction","organSystem":"Product Issues","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":265}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Chronic kidney disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Renal artery stenosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Dyspnoea exertional","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Pneumonia aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Pulmonary mass","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Aortic aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Aortic aneurysm rupture","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Aortic stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":9,"numAtRisk":265}]},{"term":"Intermittent claudication","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":265}]},{"term":"Orthostatic hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]},{"term":"Subclavian artery thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":265}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":265}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":9,"numAtRisk":265}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":265}]},{"term":"Peripheral swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":14,"numAtRisk":265}]},{"term":"Incision site haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Incision site haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":265}]},{"term":"Laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":265}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":265}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":14,"numAtRisk":265}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":265}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":265}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":265}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":265}]},{"term":"Dyspnoea exertional","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":265}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":265}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":265}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 20.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":24,"numAffected":24,"numAtRisk":265}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":true},"pointOfContact":{"title":"Bryan Randall","organization":"W. L. Gore & Associates","email":"BRandall@WLGore.com","phone":"928-864-4832"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2014-10-22","uploadDate":"2018-12-06T12:56","filename":"Prot_000.pdf","size":1167504},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2014-06-10","uploadDate":"2018-12-06T12:57","filename":"SAP_001.pdf","size":448915}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000016893","term":"Carotid Stenosis"},{"id":"D000002340","term":"Carotid Artery Diseases"},{"id":"D000003251","term":"Constriction, Pathologic"}],"ancestors":[{"id":"D000020763","term":"Pathological Conditions, Anatomical"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000001157","term":"Arterial Occlusive Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5284","name":"Carotid Artery Diseases","asFound":"Carotid Artery Diseases","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M6165","name":"Constriction, Pathologic","asFound":"Stenosis","relevance":"HIGH"},{"id":"M18928","name":"Carotid Stenosis","asFound":"Carotid Artery Stenosis","relevance":"HIGH"},{"id":"M22209","name":"Pathological Conditions, Anatomical","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":true}